119th Congress
H.R. 124
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Al Green(D-TX)
- Introduced
- Jan 3, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (0)
No cosponsors.
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic]
This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 3, 2025 · House
Referred to the House Committee on Energy and Commerce. - Jan 3, 2025
Introduced in House